Under this, Sebi will assign unique IDs to each observation in a bid to simplify the tracking of both current and historical audit issues. This new framework aims to improve data quality, ensure ...
Morton Grove, IL, January 21, 2014 – Regis Technologies, Inc., today reported that it successfully passed a recent U.S. Food & Drug Administration (FDA) audit with no Form 483 observations. Form 483 ...